Exelixis Articles
SOBI to distribute Exelixis' cancer drug Cometriq in EU
22 February 2013
Exelixis and Sanofi terminate $1 billion cancer deal
23 December 2011
Sanofi names David Meeker as chief executive of Genzyme; Exelixis hires former Genentech exec
25 October 2011
Bristol-Myers in two new deals with Exelixis, worth a potential $565 million; will retain Big Pharma legacy
12 October 2010
Leadership changes at Biogen Idec, Exelixis, Abbott, Pierre Fabre; Shionogi reorganizes in USA
2 July 2010
Showing 1-9 of 9 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
